Podcasts about Ix

Long live weird Nintendo! Last week, Nintendo released a new short film created by Nintendo Pictures...not once, not twice, but three times, and Patrick and Mark wonder if there's more than meets the eye to this new Pikmin animation. Plus, Nintendo is hit by a hacking group, Mina the Hollower is delayed, and more.The guys also talk about:Patrick's continued adventures in Hades II.Mark forsaking Dragon Quest III HD-2D in the name of more Mario Galaxy 2.The origins of Kirby and the Forgotten Land + Star-Crossed World.Final Fantasy VII, VIII, and IX getting a physical release on Switch.SUPPORT US ON PATREON: https://www.patreon.com/nintendocartridgesocietyFRIEND US ON SWITCH / SWITCH 2Patrick: SW-1401-2882-4137Mark: SW-8112-0583-0050

This week on Nintendo Pow BlockThis week on Nintendo Pow Block, Edward Varnell⁠⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Corey Dirrig break down the latest Nintendo news! Assassin's Creed Shadows has been rated by PEGI and may be coming to Nintendo Switch 2 after a retailer listing leaks its Game-Key Card version. Square Enix is finally giving Final Fantasy VII, VIII, and IX physical releases in North America this December. Meanwhile, the Nintendo Switch 2 continues to dominate with record-breaking sales, and Nintendo Pictures debuts its Close to You short films featuring Pikmin!All this and more on Nintendo Pow Block!Follow our Hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Edward Varnell⁠⁠⁠⁠⁠⁠⁠⁠⁠, Cofounder of ⁠⁠⁠⁠⁠⁠⁠⁠⁠Boss Rush Network⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Corey Dirrig⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, Founder of Boss Rush Media and the ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Boss Rush Network⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join the Boss Rush Community: Join the ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Boss Rush Network Community Discord⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow Boss Rush Network: Follow Boss Rush Network on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠X/Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bluesky⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Threads⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Support Boss Rush Network:Support Boss Rush on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and buy merch on our ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Store.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Subscribe to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Boss Rush on YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and visit our ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠website at BossRush.net⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for more great content.Thank you for your Support!Thank you for watching or listening to Nintendo Pow Block, the Nintendo podcast from Boss Rush Network! If you enjoyed the show, be sure to subscribe to the channel, give the video a Like, and hit the notification bell so you never miss an episode. If you're listening on Apple Podcasts, Spotify, or any other podcast app, please leave us a 5-star rating and a review—it really helps! For more great content, visit our website at BossRush.net. Thanks for your continued support of Nintendo Pow Block and our independent endeavor with the Boss Rush Network!

Across three millennia, the goddess Astarte was recast as the demon Astaroth: a transformation that reveals more about humanity's fear of the sacred feminine than any real change in divinity. This episode traces that metamorphosis from ancient Mesopotamian goddess to grimoire demon and modern occult archetype. Drawing on sources from biblical polemics and Renaissance demonology, as well as feminist and queer reimaginings, this exploration examines how Astaroth embodies the persistence of forbidden knowledge, gender fluidity, and spiritual defiance. Was Astaroth truly a fallen angel or the suppressed face of divine wisdom, buried under centuries of theological sabotage? CONNECT & SUPPORT

Summary of the Message: “Kingdom, Power, Glory: Quietness + Confidence = Strength” by Pastor Bryan Hudson, D.Min. I. INTRODUCTION: THE DISCIPLE'S REQUEST AND THE KINGDOM CONTEXT A. The Request: “Lord, Teach Us to Pray” (Luke 11:1; Matthew 6:9–13) Jesus models prayer for His disciples—not the Lord's prayer, but our prayer. The prayer closes with a reminder of divine ownership and sovereignty: “For Yours is the Kingdom, and the Power, and the Glory forever.” B. Meaning of the Three Realms of God Kingdom – God's rule and authority. Power – God's ability to accomplish His will. Glory – God's majesty and divine presence. These belong to God alone; not to governments, politicians, or human systems. Believers operate in a higher kingdom, with higher power, for the glory of God. II. THE KINGDOM IS LIGHT IN A DARK WORLD A. The Bright Light of God's Kingdom (Matthew 5:14) Jesus said, “You are the light of the world; a city on a hill cannot be hidden.” Christ has transferred His light to His followers. Application: You are already visible—so shine. Others are already watching, so be the light. “You may as well shine!” III. THE KINGDOM IS TRANSFORMATIVE A. The Call of the Disciples (Matthew 4:18–20) Jesus said, “Follow Me, and I will make you fishers of men.” Transformation begins when we follow; God makes us. The Kingdom changes identity and purpose. B. Cooperation with God's Transforming Power Transformation requires yielding, not striving. God's kingdom forms new purpose, power, and personhood. IV. THE KINGDOM IS FULL OF STRENGTH (Isaiah 30:15–16) “In returning and rest you shall be saved; In quietness and confidence shall be your strength; But you would not…” A. The Prophetic Context Judah sought political alliances (Egypt) instead of trusting God. God rebuked them: “You take counsel, but not of Me.” The warning: reliance on worldly systems leads to weakness and dependence. B. Worldly Systems vs. God's Kingdom Earthly systems concentrate power and wealth among a few. God's kingdom strengthens, uplifts, and liberates people. True strength is found only in God's rule. V. THE FALSE STRENGTH OF SPEED AND STRIVING A. The Futility of Running Faster “We will flee on swift horses…” — but “those who pursue you shall be swift.” You cannot outrun anxiety, distraction, or fear. The faster you run, the faster your troubles seem to chase you. Principle: The answer is not speed but stillness. B. Modern Application People try to fix weakness by posturing strength—pretending to be powerful. Strength doesn't come from acting strong but from quietness of heart and confidence in God. VI. TRUE STRENGTH ILLUSTRATED: HARRIET TUBMAN A. Example of Spiritual Strength Physically small (about 5 feet tall), formerly enslaved, but mighty in faith. Escaped 90 miles to freedom and returned to rescue ~70 others. Served as a scout and spy during the Civil War and later as an activist. B. The Source of Her Strength Quote: “I prayed to God to make me strong and able to fight.” Her strength came from God, not size or status. True strength is moral, spiritual, and rooted in trust and courage. VII. RETURNING, RESTING, AND KNOWING GOD A. Returning and Rest (Isaiah 30:15) Returning = repentance — turning back to God. Rest = tranquility and settledness. Deliverance comes through surrender, not striving. Rest is not inactivity—it is trusting the power of another (God). B. Quietness and Confidence Quietness: Calm heart; stillness of spirit. Confidence: Assurance in God's character and promises. “Be still and know that I am God” (Psalm 46:10). You know only after you be still. Stillness allows God's presence to fill the heart. C. Results of Quiet Confidence “The work of righteousness will be peace” (Isaiah 32:17). When God is with you, you can move without fear. If you are still fearful—sit back down until peace returns. VIII. THE HUMAN TENDENCY TO MOVE FASTER A. God Says: “Rest.” Humanity Says: “No.” Israel said, “We will flee on swift horses.” Principle: The human reflex is to move faster rather than trust deeper. Lesson: You need stillness, not speed. B. Trust in God, Not in Systems “Some trust in chariots, and some in horses, but we will remember the name of the Lord our God.” (Psalm 20:7) Wealth, systems, and networks can change—but God remains faithful. Even abundance (money, success) is no substitute for trust in the Lord. IX. THE POWER OF STILLNESS A. Stillness Is Productive, Not Passive God's kingdom is productive—just not busy. Stillness reorders priorities and aligns you with God's presence. It helps you reframe life's situations through faith: “It's bad, but God's got it.” “It's chaotic, but God's got me.” B. Illustration: Captain “Sully” Sullenberger During the “Miracle on the Hudson,” he acted calmly under pressure. His stillness allowed his training—and God's grace—to work. Lesson: You can't perform CPR, pilot a plane, or save a life while frantic. Stillness lets knowledge, faith, and grace operate effectively. X. THE INVITATION TO REST IN CHRIST (Matthew 11:28) “Come to Me, all you who labor and are heavy laden, and I will give you rest.” A. God's Offer vs. Humanity's Resistance Many hear this call but refuse it—choosing “swift horses” instead. Jesus invites us to stop striving and receive His rest. XI. APPLICATION AND RESPONSE 1. Return to God Daily Repent, realign, and rest—make it a daily rhythm. Don't wait for crisis to return; stay aligned continuously. 2. Seek Strength Through Quiet Time Prayer and meditation on God's Word. Meditate—turn truth over and over until it shapes your heart. 3. Value Stillness with God Over Speed Without Him Resist the culture of hurry. Strength grows in quiet confidence, not constant motion. 4. Trust That When You Stop Striving, God Starts Moving Let surrender activate divine strength. Faith rests, and rest becomes power. XII. CONCLUSION AND PRAYER Summary Statement: “Quietness + Confidence = Strength.” God's kingdom is not built on noise, speed, or display—but on returning, resting, and trusting. Closing Prayer Highlights: Thank God for His kingdom, power, and glory. Ask for grace to practice stillness, repentance, and confidence. Celebrate examples of spiritual strength (like Harriet Tubman). Reaffirm trust in God's rule: “Yours is the Kingdom, the Power, and the Glory, forever.”

LinksQuotes to get right. #runx · GitHub“People aren't supposed to look back.”Reconcilable Differences #270: We Inflated Our Pants - RelayValley Girl (1983 film) - WikipediaYork Steak House - WikipediaThe Awards for Advertising American Ads - YouTubeMerlin's Happy Place - YouTubeEdward Elgar - Enigma Variations, Op.36: IX. (Nimrod) - YouTubeDon Henley - The Boys Of Summer - YouTubeThe Ataris - The Boys of Summer - YouTubeDuck Soup (1933 film) - WikipediaAFI Movie Club: DUCK SOUP | American Film InstituteSqueeze - Is That Love? (Official Music Video) - YouTubeDeadspin | The GookieRufus T Fireflys introduction - YouTubeThe Lemonade Vendor - YouTube"This Country's Going to War" - YouTubePre-Code Hollywood - WikipediaHays Code - WikipediaAnti-Catholicism in the United States - WikipediaThe Very Weird Rules of Golden Age Hollywood: The Hays Code and the effect it still has today! - YouTubePolitics and the Star Persona of Katharine Hepburn - YouTubeGroucho Marx Dick Cavett 1969 - YouTubeSqueeze - Is That Love? (Official Music Video) - YouTube

This week we're discussing every album by ...And You Will Know Us by the Trail of Dead. Led by core members Conrad Keely and Jason Reece (who both trade off between drums, guitars and vocals), Trail of Dead is one of the most fun and ambitious post-hardcore bands around. And although they have a trademark sound, they've continued to evolve and expand their sound in countless ways. Dig it.   Intro 00:00 (The Episodes Are Back Up Now) 13:31 Band Overview 17:46 ...And You Will Know Us by the Trail of Dead 25:16 Madonna 38:21 Source Tags & Codes 49:24 Worlds Apart 1:03:47 So Divided 1:18:00 The Century of Self 1:29:40 Tao of the Dead 1:41:16 Lost Songs 1:49:23 IX 2:00:04 X: The Godless Void and Other Stories 2:09:04 XI: Bleed Here Now 2:20:26 Outro 2:34:50   ----------------------------------------------------------------------------------------------------------   Patreon https://www.patreon.com/everyalbumever   Merch https://pandermonkey.creator-spring.com/   Mike's EP: Pander Monkey on Bandcamp, Spotify, Apple,   Mike on Instagram @pandermonkey Alex on Bluesky @octatron3030 Tom on Instagram @tomosmansounds   History Tom's stuff: Music on Spotify, Apple Podcast on Spotify, YouTube Substack Website   ----------------------------------------------------------------------------------------------------------   Mike's Picks: ...And You Will Know Us by the Trail of Dead (1998) -- Best Album, Personal Favorite So Divided (2006) -- Worst Album X: The Godless Void and Other Stories (2020) -- Least Favorite   Alex's Picks: Worlds Apart (2005) -- Best Album, Personal Favorite IX (2014) -- Worst Album, Least Favorite

In this episode, Jeff is joined by his writing partner, Dialogue Doctor Coach JP Rindfleisch the IX. Jeff and JP talk about the book The Hidden Tools of Comedy by Steve Kaplan. They discuss Kaplan's theory of comedy, talk about the comedic equation, and then discuss the 8 tools of comedy.  Find Steve Kaplan's book here: https://www.amazon.com/Hidden-Tools-Comedy-Serious-Business/dp/1615931406 Check out JP's work here: https://shop.jprindfleischix.com/ Check out Jeff and JP's Kickstarter here: https://www.kickstarter.com/projects/jprindfleischix/nrds-queer-paranormal-comedy-seasons-1and2-special-editions For more on the craft of writing, go to https://dialoguedoctor.com/  

Hey there folks, this week... we live through hell with all our friends. Next week, we're onto the END of the series, finishing up part IX. Beyond that, please be sure to follow us or subscribe on your podcatcher of choice, and leave a review on iTunes, Stitcher, or wherever. It goes a long way to helping the podcast grow. You can also check out our Patreon at Patreon.com/Wordsandwhiskey Check it out! Another way you could help us out? Refer us to your friends. We love a good referral, don't we folks? Send us ANY questions to our twitter account, Instagram, or to our email. Link: https://wordsandwhiskey.show/episode/274-the-wisdom-of-crowds-part-viii

Obecnie czeska marka pojazdów Tatra kojarzy się wyłącznie z potężnymi, terenowymi ciężarówkami. Na przestrzeni prawie dwóch wieków istnienia w morawskiej Koprzywnicy produkowano jednak szereg różnego rodzaju pojazdów. Tatra ma więc na swoim koncie chociażby bardzo udany pociąg czy kilka samolotów - w tym jeden taki, którego rekordów, ustanowionych 90 lat temu, nie udało się pobić do dzisiaj. Produkowała w końcu Tatra, z powodzeniem - nawet komunistyczne limuzyny.W 93 odcinku Czechostacji wracamy wraz z Karolem Machi, historykiem motoryzacji z wrocławskiego ośrodka Pamięć i Przyszłość do rozmowy o czeskiej marce pojazdów Tatra. Opowieść, którą zaczęliśmy dwa tygodnie temu, w odcinku nr 91, nie podejmujemy jednak tam, gdzie uprzednio skończyliśmy, czyli po II wojnie światowej. Cofamy się bowiem, raz jeszcze, do czasów przedwojennych, by na chwilę porzucić cztery koła i przedstawić inne środki transportu.W rozmowie jest też sporo o historycznym kontekście II wojny światowej i czasów tuż powojennych oraz tym, jak się to wszystko odbiło na największych związanych z Tatrą nazwiskach.Sporo miejsca poświęcamy ewolucji - kolejnym modelom luksusowych pojazdów, jakie dla swoich dygnitarzy polecili Tatrze produkować czechosłowaccy komuniści. W tym kontekście pojawia się też wyprodukowany specjalnie dla Stalina kabriolet.Rozmowa urywa się nagle w momencie, w którym końca dobiega opowieść o samochodach osobowych. Wrócimy do niej za, a jakże, dwa tygodnie - wtedy, w odcinku podsumowującym historię Tatry przyjdzie kolej na pojazdy ciężarowe, które zakład z Koprzywnicy produkuje właściwie od momentu, w którym zajął się, jako trzecia marka na świecie, produkcją samochodów. I które, z powodzeniem, robi do dzisiaj.Jeśli podcast Wam się podoba i chcecie pomóc go rozwijać, możecie zostać Patronami lub Patronkami Czechostacji w serwisie Patronite. W tym tygodniu zdecydowali się na to:Anna, Bartłomiej i KinBardzo Wam dziękuję

#rozwójosobisty #coaching #medytacja Postaw kawę twórcy: https://buycoffee.to/mediteusz-----------------------------------------------PROJEKT ŻYCIE 13 X 2025 - 1 I 2026https://wiedza.mediteusz.pl/produkt/projekt-zycie/JEDYNA EDYCJA !!!-------------------------------------------------PAKIETY Z OKAZJI CODZIENNIKA #6000 https://wiedza.mediteusz.pl/kategoria-produktu/600/-----------------------------------------------WARSZTATY RATYŃSKICHhttps://jaklepiejzyc.pl/produkt/weekend-uwaznosci/KOD MEDI600------------------------------------------------HIPNOTIC STORIES - ŻYWIOŁY ZESTAW MEDYTACJI IMERSYJNYCH - DOLBY ATMOShttps://tiny.pl/8k4n3mtn-------------------------------------------OUTLEThttps://wiedza.mediteusz.pl/outlet/ALMANACH OGRANICZAJĄCYCH PRZEKONAŃhttps://wiedza.mediteusz.pl/produkt/almanach-ograniczajacych-przekonan/PRZEDSPRZEDAŻ--------------------------------------------------Nowe nagranie na buycoffee klikasz kawkę i leci do Ciebie nagraniefragment tuhttps://mediteusz.pl/audio/Czarodziej_zycia_001_wstep.mp3----------------------------------------------------WAKACJE ZMIAN 2025https://wiedza.mediteusz.pl/produkt/wakacje-zmian-2025/------------------------------------------------MEDYTACJA OGRÓD ZDROWIA - POBIERZ MP3https://tiny.pl/d-3085hgŁUKASZ GOTOWICZ - AUDIOBOOKhttps://wiedza.mediteusz.pl/produkt/lukasz-gotowicz-od-chaosu-do-swiadomosci-audiobook/------------------------------------------------WIELKA KSIĘGA AFIRMACJI https://wiedza.mediteusz.pl/produkt/wielka-ksiega-afrimacji/1000 AFIRMACJI + 2000 NAGRAŃ !!!!TYLKO 1250 SZT !--------------------------------------------------KSIĘGA DOBROSTANÓWhttps://wiedza.mediteusz.pl/produkt/ksiega-dobrostanu/PRZEDSPRZEDAŻ - TYLKO 1111 szt -----------------------------------------------------------NOWA KSIĄŻKA PROF. KRÓLICKIEGOhttps://wiedza.mediteusz.pl/produkt/feng-shui-niech-przestrzen-pracuje-dla-ciebie/PRZEDSPRZEDAŻ - 350 PIERWSZYCH Z DEDYKACJĄ AUTORA + DODATKI -----------------------------------------------------------SPOTKANIA Z WEWNĘTRZNYM DZIECKIEMhttps://wiedza.mediteusz.pl/produkt/wewnetrzne-dzieckoPRZEDSPRZEDAŻ DO 23 II 2025 -------------------------------------------------SKLEP MEDITEUSZA Z NAGRANIAMI I KURSAMIhttps://wiedza.mediteusz.pl------------------------------------------------ILUSTROWANY MUDRARZ WSPÓŁCZESNYhttps://wiedza.mediteusz.pl/produkt/ilustrowany-mudrarz-wspolczesny/ PAIERhttps://wiedza.mediteusz.pl/produkt/ilustrowany-mudrarz-wspolczesny-ebook/ EBOOK------------------------------------------ŁUKASZ GOTOWICZOD CHAOSU DO ŚWIADOMOŚCI - JAK KREOWAĆ SWOJĄ RZECZYWISTOŚĆTU KLIKNIJ: https://tiny.pl/vx06f6f4 ---------------------------------------------METODA SILVY W ŚWIECIE PIENIĄDZA - TWOJE FINASE W DOBRYM STANIEhttps://wiedza.mediteusz.pl/produkt/metoda-silvy-w-swiecie-pieniadza-ksiazka-w-twardej-oprawie/----------------------------------------------MEDYTACJA DYNAMICZNA SILVY https://wiedza.mediteusz.pl/produkt/medytacja-dynamiczna-silvy-zapanuj-nad-zyciem-i-odzyskaj-zdrowie-ksiazka/SAMOKONTROLA UMYSŁU METODĄ SILVY KSIĄŻKA !https://samokontrolaumyslu.plCODZIENNIK MOTYWACYJNY #600A 30 IX 2025 PROJEKT ŻYCIE....!!!Subskrybuj by być na bieżąco

. . . - Ó : De pescador en Galilea a discípulo cercano de Jesús, de mártir en Jerusalén a símbolo vivo en Compostela. Su tumba olvidada renació en el siglo IX con luces en un bosque gallego y, desde entonces, miles de pasos han tejido el Camino que une corazones, historias y esperanzas. Hoy, su figura ya no se asocia a espadas ni a batallas, sino a la huella humilde de cada peregrino que busca consuelo, encuentro o silencio. Santiago sigue caminando. Siempre. Si te gusta lo que hacemos, puedes apoyarnos en: ☕ Ko-fi ➡ https://ko-fi.com/nekoeteurythmia iVoox ➡️ https://www.ivoox.com/support/632772 Disfruta del contenido completo en nuestra web: nekoeteurythmia.com Si quieres participar en el programa, envíanos la historia, eventos o novedades de tu grupo al correo: nekoeteurythmia@gmail.com

durée : 00:10:46 - Le Fil de l'histoire - par : Stéphanie Duncan - La croisade des Albigeois s'est achevée en 1229 avec beaucoup de sang versé, mais sans que l'hérésie ait pu être éliminée du Languedoc. Par la voix du nouveau pape Grégoire IX, l'Église qui n'entend rien lâcher, met en place une nouvelle stratégie qui va se révéler payante : l'Inquisition. - invités : Arnaud Fossier - Arnaud Fossier : Historien français - réalisé par : Claire DESTACAMP Vous aimez ce podcast ? Pour écouter tous les autres épisodes sans limite, rendez-vous sur Radio France.

Agradece a este podcast tantas horas de entretenimiento y disfruta de episodios exclusivos como éste. ¡Apóyale en iVoox! . . . - Ó : De pescador en Galilea a discípulo cercano de Jesús, de mártir en Jerusalén a símbolo vivo en Compostela. Su tumba olvidada renació en el siglo IX con luces en un bosque gallego y, desde entonces, miles de pasos han tejido el Camino que une corazones, historias y esperanzas. Hoy, su figura ya no se asocia a espadas ni a batallas, sino a la huella humilde de cada peregrino que busca consuelo, encuentro o silencio. Santiago sigue caminando. Siempre. Si te gusta lo que hacemos, puedes apoyarnos en: ☕ Ko-fi ➡ https://ko-fi.com/nekoeteurythmia iVoox ➡️ https://www.ivoox.com/support/632772 Disfruta del contenido completo en nuestra web: nekoeteurythmia.com Si quieres participar en el programa, envíanos la historia, eventos o novedades de tu grupo al correo: nekoeteurythmia@gmail.comEscucha este episodio completo y accede a todo el contenido exclusivo de NEKO ET EURYTHMIA ®. Descubre antes que nadie los nuevos episodios, y participa en la comunidad exclusiva de oyentes en https://go.ivoox.com/sq/632772

#rozwójosobisty #coaching #medytacja Postaw kawę twórcy: https://buycoffee.to/mediteusz-------------------------------------------------PAKIETY Z OKAZJI CODZIENNIKA #6000 https://wiedza.mediteusz.pl/kategoria-produktu/600/-----------------------------------------------WARSZTATY RATYŃSKICHhttps://jaklepiejzyc.pl/produkt/weekend-uwaznosci/KOD MEDI600------------------------------------------------HIPNOTIC STORIES - ŻYWIOŁY ZESTAW MEDYTACJI IMERSYJNYCH - DOLBY ATMOShttps://tiny.pl/8k4n3mtn-------------------------------------------OUTLEThttps://wiedza.mediteusz.pl/outlet/ALMANACH OGRANICZAJĄCYCH PRZEKONAŃhttps://wiedza.mediteusz.pl/produkt/almanach-ograniczajacych-przekonan/PRZEDSPRZEDAŻ--------------------------------------------------Nowe nagranie na buycoffee klikasz kawkę i leci do Ciebie nagraniefragment tuhttps://mediteusz.pl/audio/Czarodziej_zycia_001_wstep.mp3----------------------------------------------------WAKACJE ZMIAN 2025https://wiedza.mediteusz.pl/produkt/wakacje-zmian-2025/------------------------------------------------MEDYTACJA OGRÓD ZDROWIA - POBIERZ MP3https://tiny.pl/d-3085hgŁUKASZ GOTOWICZ - AUDIOBOOKhttps://wiedza.mediteusz.pl/produkt/lukasz-gotowicz-od-chaosu-do-swiadomosci-audiobook/------------------------------------------------WIELKA KSIĘGA AFIRMACJI https://wiedza.mediteusz.pl/produkt/wielka-ksiega-afrimacji/1000 AFIRMACJI + 2000 NAGRAŃ !!!!TYLKO 1250 SZT !--------------------------------------------------KSIĘGA DOBROSTANÓWhttps://wiedza.mediteusz.pl/produkt/ksiega-dobrostanu/PRZEDSPRZEDAŻ - TYLKO 1111 szt -----------------------------------------------------------NOWA KSIĄŻKA PROF. KRÓLICKIEGOhttps://wiedza.mediteusz.pl/produkt/feng-shui-niech-przestrzen-pracuje-dla-ciebie/PRZEDSPRZEDAŻ - 350 PIERWSZYCH Z DEDYKACJĄ AUTORA + DODATKI -----------------------------------------------------------SPOTKANIA Z WEWNĘTRZNYM DZIECKIEMhttps://wiedza.mediteusz.pl/produkt/wewnetrzne-dzieckoPRZEDSPRZEDAŻ DO 23 II 2025 -------------------------------------------------SKLEP MEDITEUSZA Z NAGRANIAMI I KURSAMIhttps://wiedza.mediteusz.pl------------------------------------------------ILUSTROWANY MUDRARZ WSPÓŁCZESNYhttps://wiedza.mediteusz.pl/produkt/ilustrowany-mudrarz-wspolczesny/ PAIERhttps://wiedza.mediteusz.pl/produkt/ilustrowany-mudrarz-wspolczesny-ebook/ EBOOK------------------------------------------ŁUKASZ GOTOWICZOD CHAOSU DO ŚWIADOMOŚCI - JAK KREOWAĆ SWOJĄ RZECZYWISTOŚĆTU KLIKNIJ: https://tiny.pl/vx06f6f4 ---------------------------------------------METODA SILVY W ŚWIECIE PIENIĄDZA - TWOJE FINASE W DOBRYM STANIEhttps://wiedza.mediteusz.pl/produkt/metoda-silvy-w-swiecie-pieniadza-ksiazka-w-twardej-oprawie/----------------------------------------------MEDYTACJA DYNAMICZNA SILVY https://wiedza.mediteusz.pl/produkt/medytacja-dynamiczna-silvy-zapanuj-nad-zyciem-i-odzyskaj-zdrowie-ksiazka/SAMOKONTROLA UMYSŁU METODĄ SILVY KSIĄŻKA !https://samokontrolaumyslu.plCODZIENNIK MOTYWACYJNY #600 29 IX 2025 KWADRANS KTÓRY ZMIENIA ŻYCIE - JUBILEUSZOWE WYDANIE !!!!Subskrybuj by być na bieżąco

Questions & Answers IX - Rev. 3:14-17

Le prime pagine dei principali quotidiani nazionali commentate in rassegna stampa da Davide Giacalone. L'appello di Mattarella alla Flottilla, lo show di Netanyahu all'ONU, il caso Garlasco. Motomondiale. Alle 8 il via alla gara sprint della classe MotoGp al Gp del Giappone, pista di Motegi. Il nostro inviato speciale Max Biaggi. Garlasco. Gli ultimi sviluppi. Indagato l'ex procuratore di Pavia Venditti, che sembra abbia ricevuto soldi dalla famiglia Sempio per archiviare le indagini su Andrea Sempio. in diretta il giornalista Carmelo Abbate. WWF Urban Nature: la città che riscopre la natura. Urban Nature è un'iniziativa promossa dal WWF Italia, giunta alla sua IX edizione nel 2025, che mira a riportare la natura al centro delle città italiane. Si svolge ogni anno nel primo weekend di ottobre — quest'anno il 4 e 5 ottobre — e coinvolge cittadini, istituzioni e associazioni in una rete di eventi diffusi su tutto il territorio nazionale. 1.700 piazze coinvolte e più di 150 iniziative solo nel 2024. L'obiettivo è stimolare una nuova cultura urbana, dove la natura non è un ornamento ma un elemento strutturale della pianificazione. Con Eva Alessi, Responsabile sostenibilità del WWF Italia. All'interno di Non Stop News, con Barbara Sala, Lucrezia Bernardo e Dario Vanacone.

Entre los siglos IX y X, numerosas ciudades mayas sufrieron una crisis repentina y acabaron siendo abandonadas. Entre las causas del llamado colapso maya se cuentan la sobreexplotación de los recursos y la espiral de guerras y conflictos intestinos.

Send us a textIn this episode, we cover the last few years of John Vatatzes' reign, and the crazy events that surrounded them. The Seventh Crusade was kicked off by King Louis the IX, and just like the 5th crusade, they attacked the city of Damietta, and then overextended their armies and ultimately lost everything to the Ayyubids, but we also cover the rise of the Mamluks, and the final battle in the life of Frederick II. The rise of the Empire of Nicaea is about to take a turn as its allies crumble, and the Laskarid Dynasty enters its final years.The History of Modern Greece Podcast covers the events from Ancient Greece, the Roman Empire, and the fall of Constantinople in 1453, to the years under the Ottoman Empire, and 1821 when the Greeks fought for independence... all the way to the modern-day.Website: www.moderngreecepodcast.comSOCIAL MEDIA: Go here to chat with us. https://www.instagram.com/historyofmodern%20greece/https://www.facebook.com/profile.php?id=61578023316172Music by Mark Jungerman: www.marcjungermann.comCheck out our 2nd Podcast: www.antecedors.com

Do dnešnej epizódy podcastu Flešbeky si moderátor Ivan pozval Jána „Honzíka“ Goroľa, herca a lídra kapely GPS, ktorý je aktívne zapojený do gréckokatolíckej rómskej misie. Ján opisuje, ako sa z vyrastania v takmer neveriacej rodine v rómskej osade dostal k živej viere v Ježiša, a spomína moment, keď ako malý chlapec takmer prišiel o život. Hovorí aj o svojej ceste k profesionálnemu herectvu a o hudobných začiatkoch kapely GPS, v ktorej pôsobí ako spevák. V podcaste sa dotýka aj tém gréckokatolíckej misie, spomína zážitok zo spevu pred pápežom Františkom na Luníku XI. a rozpráva o svojom hudobnom pôsobení na Godzone tour.0:00 Úvod a predstavenie2:06 Miska otázok2:37 Čo by si odkázal svojmu mladšiemu ja?3:13 Aký film alebo seriál by najvernejšie opísal tvoj minulý týždeň?3:55 Aká maličkosť ti naposledy spravila radosť?4:32 Aké je tvoje najobľúbenejšie jedlo?5:56 Súťaž o knihu Prežívať Otcovo objatie: https://www.godzoneshop.sk/produkt/prezivat-otcovo-objatie-nove-vydanie-jack-frost/6:28 Úryvok z knihy Prežívať Otcovo objatie8:30 Honzíkov príbeh obrátenia17:47 10 minút mŕtvy?! 22:53 Divadelná kariéra30:12 Honzíkova cesta k hudbe a vznik kapely GPS 34:49 Čím sú výnimočné rómske chvály?37:40 Ako prebieha evanjelizácia v rómskych osadách?41:19 Ako funguje Gréckokatolícka rómska misia?45:36 Spev pred pápežom Františkom na Luníku IX. 48:54 Prvá skúsenosť s Godzone tour52:16 Služba na turné58:11 Poďakovanie a rozlúčenie

Przeszkadzają im geje, Ukraińcy i demokracja. Chcą wystąpić z Unii Europejskiej i NATO. Mówiąc o wolności słowa domagają się prawa do kłamstwa, równocześnie chętnie nawołują do kneblowania innych. Z sympatią patrzą w stronę Moskwy - ten opis pasuje do dwóch, tylko pozornie ideologicznie odmiennych partii. Mowa o skrajnie prawicowej SPD i komunistach. Takich prawdziwych, z korzeniami w czasach słusznie minionych. Pierwsi na pewno - znów, znajdą się po październikowych wyborach w nowym parlamencie. Drudzy mają całkiem spore szanse na to, by do niego wrócić. W okolicach pięcioprocentowego progu wyborczego ląduje też, według sondaży, ugrupowanie Zmotoryzowanych, którego program nie różni się specjalnie od tego, co proponują komuniści i skrajna prawica.W kolejnych przedwyborczym odcinku dr Martyna Wasiuta, prowadząca portal Czeska Polityka związana z Tygodnikiem Powszechnym politolożka opisuje czeskie ugrupowania antysystemowe, które w sumie mogą zebrać około 1/5 wszystkich głosów. Niby dużo, równocześnie jednak mogą nie odegrać zupełnie żadnej roli w układaniu powyborczych puzzli - komuniści i Zmotoryzowani wcale nie mają pewności, że do parlamentu w ogóle wejdą, z SPD nikt - łącznie z faworytem sondaży - ugrupowaniem ANO Andreja Babisza, nie ma ochoty się układać. W rozmowie jest też m.in. o jamajskich rytmach, którymi o wyborców walczą brunatni, o prokremlowskich propagandzistach, z których część wylądowała na listach SPD, część u komunistów. I mitomanie z kwadratową szczęką, który jest liderem nadziei kierowców, ma słabość do III Rzeszy i stoi na czele trzyosobowego klubu miłośników Jaguara.W podsumowaniu odcinka usłyszycie też trochę na zupełnie inny - chociaż może nie do końca, temat. Czyli historię ostatnich słów twórcy Czechosłowacji, Tomasza Garrigue Masaryka, który co prawda zmarł prawie 90 lat temu, ale jego "ostatnie słowa" poznaliśmy w ubiegłym tygodniu. Chociaż, jak zwykle, to trochę bardziej skomplikowane.Tutaj znajdziecie cały utwór kampanijny SPD, którego początek wykorzystuję w treści odcinka.A tu zapis transmisji z otwierania koperty i odczytywania ostatnich słów TGM.Jeśli podcast Wam się podoba i chcecie pomóc go rozwijać, możecie zostać Patronami lub Patronkami Czechostacji w serwisie Patronite. W tym tygodniu zdecydowali się na to:Agata, Dominik i PiotrBardzo Wam dziękuję

Kapolri Jenderal Listyo Sigit Prabowo Membentuk Tim Transformasi Reformasi Polri. Tim Ini Tertuang Dalam Sprin Nomor 2749,IX,2025 Tertanggal 17 September 2025. Tim Reformasi Terdiri Dari 52 Perwira Tinggi Dan Menengah Polri, Tugasnya Melakukan Evaluasi Dan Memperkuat Reformasi Di Internal Kepolisian.#Polri #Reformasi #kapolri #listyosigitprabowo

Ladesäulen, Reichweite und keine Heizung an kalten Tagen? Susanne und Nicolas wollen eine Woche testen, wie es ist, mit dem E-Auto unterwegs zu sein. Dabei treffen sie Tuner, die Pannenhilfe und jede Menge Leute aus dem Business und fahren auch ins Batteriewerk von VW. In der ersten Folge erklären Sie uns, warum sie das tun und was ihre Motivation ist. Host Niels Walker weiß übrigens, dass Susannes privates Auto alles andere als modern ist... LINKS: Hier könnt ihr online nachverfolgen, wo die beiden schon waren: ndr.de/etour

The Apostles IX - Philip - Acts 22:16

La Asociación Nacional de Establecimientos Financieros y de Crédito y Fundación ONCE celebran el 28 de septiembre la “IX carrera solidaria por la educación financiera y la inclusión”. El objetivo es mejorar la formación de las personas con discapacidad intelectual o con dificultades de aprendizaje.Escuchar audio

Die Rückfallzieher nähern sich unaufhaltsam ihrer 250. Ausgabe, aus den verschüchterten Rehkitzlein Meigl und Guido sind röhrende Zwölfender geworden, denen eine Waldes-Lichtung zur Präsentation ihrer mächtigen Geweihe und weltmännischen Allwissenheit längst nicht mehr reicht. Und so spielen sie sich bei der jüngsten Podcast-Ausgabe selbstverliebt-wiederkäuend die Bälle zu, hirschen ohne Rücksicht auf Sinn, Verstand und Dramaturgie von Thema zu Thema. Im Zentrum windschiefer Ansichten stehen Fragen, die leider nur entfernt mit dem Kölner Gastspiel in der Red-Bull-Arena zu tun haben. Weil Meigl eine enge Facebook-Freundschaft mit Effzeh-Maskottchen Hennes pflegt, erfahren die Fans der Rückfallzieher alles über die Geißbock-Dynastie, die seit 1966 zum 1. FC Köln gehört und ohne Hennes I bis IX nicht denkbar wäre. Meigl schaut via Webcam nahezu stündlich, was Hennes im Kölner Zoo so alles treibt, welche Karotten er mümmelt und Herzdame er gerade bezirzt. Der leibhaftige Hennes tritt nur bei Heimspielen der jecken Kölner am Seitenrand in Erscheinung, auswärts müssen die Männer um den Ex-Leipziger Tom Krauß (ein Schäfersches Interview mit Krauß erscheint am Sonnabend) ohne ihren Geißbock auskommen. Das RB-Maskottchen heißt übrigens Bulli, riecht nicht ganz so verwegen wie Hennes und ist auffallend gut zu Fuß. Dass im Bulli-Kostüm immer der RB-Profi steckt, der unter der Woche schlechter als alle anderen trainiert hat, ist nur rein Gerücht. In den wenigen lichten Momenten ihres Hörspiels widmen sich die röhrenden Zwölfender Meigl und Guido der mannschaftlich geschlossenen Mannschaftsleistung beim Leipziger 1:0 in Mainz am Rhein. Guido gießt Essig in den Kelch der Freude, wirft spitz ein, dass zwei, drei Rote Bullen so viel Kohle einstreichen, wie der komplette Mainzer Kader zusammen und Geld eben doch Tore schießt bzw. verhindert. Meigl sagt, dass Mainz 2024/25 vor RB ins Ziel gekommen und der schnöde Mammon überbewertet ist. Hirschige Einigkeit herrscht über den Ausgang der Partie. Meigl tippt 1:1, Guido 4:1. Präsentiert werden Meigl und Guido vom legendären Hotel & Restaurant Hiemann in der Delitzscher Landstraße 75 in Wiederitzsch. Dieses großartige Kleinod ist seit 30 Jahren Familien geführt, bei Chef Jens Hiemann laufen alle Lebensadern der gastronomischen Vorzeige-Einrichtung zusammen. Meigl war unlängst da und wählte nach einem Blick in den Spiegel die Iberico-Bäckchen mit ohne Trüffel. Lob, Lob oder Lob? Bitte an g.schaefer@lvz.de mailen.

Czy wiedzieliście o tym, że koncepcję karoserii aerodynamicznej, redukującej spalanie i poprawiającej właściwości jezdne po raz pierwszy w seryjnie produkowanych samochodach zastosowała właśnie Tatra? I że nie były to wcale ciężarówki? Bo w okresie międzywojennym ta wywodząca się z malutkiej Koprzywnicy w czeskiej części Śląska, marka produkowała również - a może głównie, samochody osobowe. Samochody, które zmotoryzowały Europę.91 odcinek Czechostacji, pierwszy z serii poświęconej czechosłowackiej i czeskiej motoryzacji, opowiada właśnie o Tatrze. W historię tej marki wprowadza mnie Karol Machi, historyk motoryzacji z wrocławskiego ośrodka Pamięć i Przyszłość, zarazem kolekcjoner i autor poświęconego starym czechosłowackim pojazdom instagramowego profilu Machiny.Swoją drogą - Tatra doskonale nadaje się do tego, by pokazywać złożoną, wymykającą się prostym narodowościowym kalkom historię terenów dzisiejszych Czech. U początków Tatr leży bowiem zakład założony w niewielkim miasteczku tzw. wówczas Austriackiego Śląska, części Królestwa Czech. W samym miasteczku dominowali akurat Czesi, ale wcale nie jesteśmy pewni w jakim języku mówił w domu Ignác Šustala, w wielu ówczesnych dokumentach zapisywany jako Ingaz Schustala. Wiemy natomiast, że jego matka pochodziła z Tychów. Šustala zaczynał od powozów i bryczek, potem robił wagony kolejowe, w 1897 roku wypuścił w świat pierwszy samochód - Presidenta. Wówczas jeszcze pod marką NW, skrótem od Nesselsdorfer Wagenbau-Fabriks-Gesellschaft, czyli po prostu neselsdorfską fabryką pojazdów.W odcinku jest też m.in. o aerodynamicznych limuzynach, o samochodzie, którym ewidentnie inspirował się projektując garbusa Ferdynand Porsche i o jednej czechosłowackiej komedii, która dała imię samochodowi, który w międzywojniu trafił pod czechosłowackie strzechy. W związku z tym jest nawet w odcinku jedna piosenka ;) Tę opowieść o Tatrze kończymy w 1945 roku, ale będzie ona miała swoją kontynuację już za dwa tygodnie - wówczas opowiemy o powojennych modelach marki z Koprzywnicy. I o tym, co i gdzie zwiedzać, jeśli będziecie chcieli zapoznać się z Tatrą bliżej.Jeśli podcast Wam się podoba i chcecie pomóc go rozwijać, możecie zostać Patronami lub Patronkami Czechostacji w serwisie Patronite. W tym tygodniu zdecydowali się na to:Eliza, Jiří, Olga i PiotrBardzo Wam dziękuję

#rozwójosobisty #coaching #medytacja Postaw kawę twórcy: https://buycoffee.to/mediteusz-----------------------------------------------KANAŁ GITAROWY KSANTYPAhttps://www.youtube.com/@UCiNm76RwgYAzwwRbLxFTsJQ -----------------------------------------------HIPNOTIC STORIES - ŻYWIOŁY ZESTAW MEDYTACJI IMERSYJNYCH - DOLBY ATMOShttps://tiny.pl/8k4n3mtn-------------------------------------------OUTLEThttps://wiedza.mediteusz.pl/outlet/ALMANACH OGRANICZAJĄCYCH PRZEKONAŃhttps://wiedza.mediteusz.pl/produkt/almanach-ograniczajacych-przekonan/PRZEDSPRZEDAŻ--------------------------------------------------Nowe nagranie na buycoffee klikasz kawkę i leci do Ciebie nagraniefragment tuhttps://mediteusz.pl/audio/Czarodziej_zycia_001_wstep.mp3----------------------------------------------------WAKACJE ZMIAN 2025https://wiedza.mediteusz.pl/produkt/wakacje-zmian-2025/------------------------------------------------MEDYTACJA OGRÓD ZDROWIA - POBIERZ MP3https://tiny.pl/d-3085hgŁUKASZ GOTOWICZ - AUDIOBOOKhttps://wiedza.mediteusz.pl/produkt/lukasz-gotowicz-od-chaosu-do-swiadomosci-audiobook/------------------------------------------------WIELKA KSIĘGA AFIRMACJI https://wiedza.mediteusz.pl/produkt/wielka-ksiega-afrimacji/1000 AFIRMACJI + 2000 NAGRAŃ !!!!TYLKO 1250 SZT !--------------------------------------------------KSIĘGA DOBROSTANÓWhttps://wiedza.mediteusz.pl/produkt/ksiega-dobrostanu/PRZEDSPRZEDAŻ - TYLKO 1111 szt -----------------------------------------------------------NOWA KSIĄŻKA PROF. KRÓLICKIEGOhttps://wiedza.mediteusz.pl/produkt/feng-shui-niech-przestrzen-pracuje-dla-ciebie/PRZEDSPRZEDAŻ - 350 PIERWSZYCH Z DEDYKACJĄ AUTORA + DODATKI -----------------------------------------------------------SPOTKANIA Z WEWNĘTRZNYM DZIECKIEMhttps://wiedza.mediteusz.pl/produkt/wewnetrzne-dzieckoPRZEDSPRZEDAŻ DO 23 II 2025 -------------------------------------------------SKLEP MEDITEUSZA Z NAGRANIAMI I KURSAMIhttps://wiedza.mediteusz.pl------------------------------------------------ILUSTROWANY MUDRARZ WSPÓŁCZESNYhttps://wiedza.mediteusz.pl/produkt/ilustrowany-mudrarz-wspolczesny/ PAIERhttps://wiedza.mediteusz.pl/produkt/ilustrowany-mudrarz-wspolczesny-ebook/ EBOOK------------------------------------------ŁUKASZ GOTOWICZOD CHAOSU DO ŚWIADOMOŚCI - JAK KREOWAĆ SWOJĄ RZECZYWISTOŚĆTU KLIKNIJ: https://tiny.pl/vx06f6f4 ---------------------------------------------METODA SILVY W ŚWIECIE PIENIĄDZA - TWOJE FINASE W DOBRYM STANIEhttps://wiedza.mediteusz.pl/produkt/metoda-silvy-w-swiecie-pieniadza-ksiazka-w-twardej-oprawie/----------------------------------------------MEDYTACJA DYNAMICZNA SILVY https://wiedza.mediteusz.pl/produkt/medytacja-dynamiczna-silvy-zapanuj-nad-zyciem-i-odzyskaj-zdrowie-ksiazka/SAMOKONTROLA UMYSŁU METODĄ SILVY KSIĄŻKA !https://samokontrolaumyslu.plCODZIENNIK MOTYWACYJNY #599 15 IX 2025 USPOKÓJ SERCE A ZMIENI SIĘ WSZYSTKO....Subskrybuj by być na bieżąco

Conheço as tuas obras, que nem é frio nem quente; quem dera fosse um ou outro. Assim, porque é morno, o vomitarei. Como diz: Sou rico, estou enriquecido, e de nada tenho falta (Salmos 23); e não sabe que é um desgraçado, e miserável, e pobre, e cego, e nu. Melhor seria, que de mim comprasse "ouro" provado no fogo, para enriquecer; roupas limpas, para vestir, e não aparecer a vergonha da tua nudez; e colírio nos olhos, para ver. Se a Justiça de vocês não exceder dos fanáticos líderes religiosos, de modo nenhum entrarão no reino dos céus. Apocalipse 3:15-18Mateus 5:20 Veio o Juízo do Senhor, aos filhos do fanáticos líderes de Judá: Dizem: Não veio ainda o tempo, o tempo que a casa deve ser edificada. Por acaso é para vocês acumularem riquezas, enquanto esta  casa fica vazia? Esperavam muito e veio a ser pouco; o pouco que trouxeram, eu destrui com um sopro. Por causa da minha casa, que está vazia, enquanto acumulam para satisfazer os próprios interesses. Por isso castigo. Trabalhem! Líderes e todo povo, segundo a promessa que fiz. Farei tremer os céus e a terra, o mar e a terra seca; e todas as nações, e virão coisas de grande valor, e encherei a casa de glória. Minha é a prata, e meu é o ouro. A glória da última casa será maior do que a da primeira, e neste lugar darei a paz. Lembrem-se dos Estatutos e Juízos, antes que se lançasse pedra sobre pedra. Há semente no depósito? Antes as árvores não davam os seus frutos.Ageu 1:1-4,9-11; 2:4-9,15,19Apocalipse 10:1-3; 18:4-5; 13:16-18; 6:12-17; 20:1-2,12-15; 22:16,14-15 Se cumpriu as Escrituras! Art. 21. Compete à União: I – manter relações com Estados estrangeiros e participar de organizações internacionais; II – declarar a guerra e celebrar a paz;III – assegurar a defesa nacional; IV – permitir, nos casos previstos em lei complementar, que forças estrangeiras transitem pelo território nacional ou nele permaneçam temporariamente; V – decretar o estado de sítio, o estado de defesa e a intervenção federal; VI – autorizar e fiscalizar a produção e o comércio de material bélico; VII – emitir moeda;VIII – administrar as reservas cambiais do País e fiscalizar as operações de natureza financeira, especialmente as de crédito, câmbio e capitalização, bem como as de seguros e de previdência privada; IX – elaborar e executar planos nacionais e regionais de ordenação do território e de desenvolvimento econômico e social; X – manter o serviço postal e o correio aéreo nacional; XI – explorar, diretamente ou mediante autorização, concessão ou permissão, os serviços de telecomunicações, nos termos da lei, que disporá sobre a organização dos serviços, a criação de um órgão regulador e outros aspectos institucionais; Constituição Federal - Edição STF

Head to https://squarespace.com/jonsolo to save 10% off your first purchase of a website or domain using code JONSOLO! Thanks to Squarespace for sponsoring the show!

¡Juega y gana gratis con Descifrando a León!Entérate antes de todos de lo que pasa dentro del Vaticano en www.descifrandoaleon.com, ¡Regístrate gratis! Sigue a Inés San Martín a Javier Martínez Brocal y a José Manuel De Urquidi.Segmentos de hoy:La Voz del Papa Las 5 Noticias de la Semana por Javier, más el bonus Análisis de la Semana por InésEl Archivo de los Leones (León IX) por Javier¿Qué tanto saben los expertos de los santos?La Comunidad de León (¡Juega aquí!)La Recomendación Online de la Semana Homilía Remix ++++++++++++++++++++++++++++Este episodio es posible gracias a Amen Apps, la plataforma en la que puedes obtener consejos y ayuda espiritual de sacerdotes y religiosos 24x7.Descarga el app gratis en:AndroidiPhonePágina AmenUn podcast de Juan Diego Network

Mark and Alex are back with their second-to-last episode in Final Fantasy X! With all of the side content and story just about finished, the boys make their way back into Sin, past the point of no return. The party finally comes face to face with Jecht and everyone knows what must be done...If you're searching for the beginning of the Final Fantasy X or IX series, check the quick info below!Start of the Final Fantasy X series is ⁠⁠⁠⁠⁠⁠⁠⁠⁠episode 43⁠⁠⁠⁠⁠⁠⁠⁠⁠Start of the Final Fantasy IX series is ⁠⁠⁠⁠⁠⁠⁠⁠⁠episodes 6⁠

hour one: "sweet georgia brown" (live excerpt of private jam from joe brazil's basement in detroit on sep 25, 1958) john coltrane "the mallard variations - cut and dissolve" david gerard "the mallard variations - variation VII" david gerard "an irrational root - r13 - the triangled" church of the annihilation "kontrast" contrastz "its all a bit of a blur" tim holehouse "stupid" (part 2 of 5) bogdan raczynski "fuerza 03" frente abierto "the mallard variations - variation IX" david gerard hour two: "the mallard variations - variation III" david gerard "stables" dave gerard and the watchmen "klee doll" (excerpt) victoria shen "where" torpedo "certified guitar pedal" (prelude) david gerard "the mallard variations - echosphere" david gerard "love" (excerpt) latex "I did not mean to turn you on" (dub you on - candy bomber version) re-201 ft. peter heppner & mika bajinsky "the mallard variations - cinematic counterpoint" david gerard hour three: "the mallard variations - variation V" david gerard "days of rain" it's ok! "abstract deductions" immr "prelude - topographic" david gerard "the temporal nature of things" david gerard "the red trickle" eugene chadbourne "random canyon" (live in detroit 1965) the holy modal rounders "delta jig d'agadir" muskeg mudsuck "we'll all go to heaven when the devil goes blind" up around the sun "untraveled" david gerard & keith richie

Dr. Pedro Barata and Dr. Rana McKay discuss the integration of innovative advances in molecular imaging and therapeutics to personalize treatment for patients with renal cell and urothelial carcinomas. TRANSCRIPT Dr. Pedro Barata: Hello, I'm Dr. Pedro Barata, your guest host of By the Book, a podcast series featuring insightful conversations between authors and editors of the ASCO Educational Book. I'm a medical oncologist at University Hospitals Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I'm also an associate editor of the ASCO Educational Book. Now, we all know the field of genitourinary cancers (GU) is evolving quite rapidly, and we have new innovations in molecular imaging as well as targeted therapeutics. Today's episode will be exploring novel approaches that are transforming the management of renal cell and urothelial carcinomas and also their potential to offer a more personalized treatment to patients. For that, joining for today's discussion is Dr. Rana McKay, a GU medical oncologist and professor at University of California San Diego. Dr. McKay will discuss her recently published article titled, “Emerging Paradigms in Genitourinary Cancers: Integrating Molecular Imaging, Hypoxia-Inducible Factor-Targeted Therapies, and Antibody-Drug Conjugates in Renal Cell and Urothelial Carcinomas.”  Our full disclosures are available in the transcript of this episode.  And with that, Rana McKay, great to have you on the podcast today. Dr. Rana McKay: Oh, thank you so much, Dr. Barata. It's really wonderful to be here with you. So, thanks for hosting. Dr. Pedro Barata: No, thanks for taking the time, and I'm looking forward to this conversation. And by the way, let me start by saying congrats on a great article in the Educational Book. Really super helpful paper. I'm recommending it to a lot of the residents and fellows at my own institution. I would like to first ask you to kind of give our listeners some context of how novel approaches in the molecular imaging as well as targeted therapeutics are actually changing the way we're managing patients with GU, but specifically with renal cell carcinoma and urothelial carcinoma. So, what are the areas you would call out as like being big areas for innovation in this context, and why are they important? Dr. Rana McKay: Very good question. And I think this is really what this article highlights. It highlights where are we going from an imaging diagnostics standpoint? Where are we going from a therapeutic standpoint? And I think if we have to step back, from the standpoint of diagnostics, we've seen PET imaging really transform diagnostics in prostate cancer with the advent of PSMA PET imaging, and now PSMA PET imaging is used as a biomarker for selection for theranostics therapy. And so, we're starting to see that enter into the RCC landscape, enter into the urothelial cancer landscape to a lesser extent. And I think it's going to potentially be transformative as these tools get more refined. I think when we think about therapeutics, what's been transformative most recently in the renal cell carcinoma landscape has been the advent of HIF2α inhibition to improve outcomes for patients. And we have seen the approval of belzutifan most recently that has reshaped the landscape. And now there's other HIF2α inhibitors that are being developed that are going to be further important as they get refined. And lastly, I think when we think about urothelial carcinoma, the greatest transformation to treatment in that context has been the displacement of cisplatin and platinum-based chemotherapy as a frontline standard with the combination of enfortumab vedotin plus pembrolizumab. And we've seen antibody-drug conjugates really reshape treatment and tremendously improve outcomes for patients. So, I think those are the three key areas of interest. Dr. Pedro Barata: So with that, let's focus first on the imaging and then we'll get to the therapeutic area. So, we know there's been a paradigm shift, really, when prostate-specific targets emerged as tracers for PET scanning. And so, we now commonly use prostate-specific membrane antigen, or PSMA-based PET scanning, and really transform how we manage prostate cancer. Now, it appears that we're kind of seeing a similar wave in renal cell carcinoma with the new radiotracer against the target carbonic anhydrase IX. What can you tell us about this? And is this going to be available to us anytime soon? And how do you think that might potentially change the way we're managing patients with RCC today? Dr. Rana McKay: First, I'll step back and say that in the context of PSMA PET imaging, we have actually been able to better understand RCC as well. So, we know that PSMA is expressed in the neovasculature of tumors, and it can actually be used to detect renal cell carcinoma tumors. It has a detection rate of about 84% when used for detection. And so, you know, I don't think it's just restricted to carbonic anhydrase IX, but we will talk about that. So, PSMA expressed in the neovasculature has a detection rate of around 84%, particularly if we're looking at clear cell RCC. CAlX is overexpressed in clear cell RCC, and it's actually used in diagnosing renal cell carcinoma when we think of CAlX IHC for diagnosing clear cell RCC. And now there are CAlX PET tracers. The first foray was with the ZIRCON study that was actually an interestingly designed study because it was designed to detect the likelihood of PET imaging to identify clear cell RCC. So, it was actually used in the early diagnostics setting when somebody presents with a renal mass to discriminate that renal mass from a clear cell versus a non-clear cell, and it was a positive study. But when I think about the potential application for these agents, you know, I think about the entire landscape of renal cell carcinoma. This is a disease that we do treat with metastasis-directed therapy. We have certainly seen patients who've undergone metastasectomy have long, durable remissions from such an approach. And I think if we can detect very early onset oligometastatic disease where a metastasis-directed therapy or SABR could be introduced - obviously tested in a trial to demonstrate its efficacy - I think it could potentially be transformative. Dr. Pedro Barata: Wonderful. It's a great summary, and I should highlight you are involved in some of those ongoing studies testing the performance of this specific PET scanning for RCC against conventional imaging, right? And to remind the listeners, thus far, for the most part, we don't really do FDG-PET for RCC. There are some specific cases we do, but in general, they're not a standard scanning. But maybe that will change in the future. Maybe RCC will have their own PSMA-PET. And to your point, there's also emerging data about the role of PSMA-PET scanning in RCC as well, as you very elegantly summarized. Wonderful. So, let me shift gears a little bit because you did, in your introduction, you did highlight a novel MOA that we have in renal cell carcinoma, approved for use, initially for VHL disease, and after that for sporadic clear cell renal cell carcinoma. We're talking about hypoxia-inducible factor 2-alpha inhibitors, or HIF2α inhibitors, such as belzutifan. But there's also others coming up. So, as a way to kind of summarize that, what can you tell us about this breakthrough in terms of therapeutic class, this MOA that got to our toolbox of options for patients with advanced RCC? Tell us a little bit what is being utilized currently in the management of advanced RCC. And where do you see the future going, as far as, is it moving early on? Is it getting monotherapy versus combinations? Maybe other therapies? What are your thoughts about that? What can you tell us about it? Dr. Rana McKay: Belzutifan is a first-in-class HIF2α inhibitor that really established clinical validation for HIF2α as a therapeutic target. When we think about the activity of this agent, the pivotal LITESPARK-005 trial really led to the approval of belzutifan in patients who were really heavily pretreated. It was patients who had received prior IO therapy, patients who had received prior VEGF-targeted therapy. And in the context of this study, we saw a median PFS of 5.6 months, and there did seem to be a tail on the curve when you looked at the 12-month PFS rate with belzutifan. It was 33.7% compared to 17.6% with everolimus. And then when we look at the response rate, it was higher with belzutifan on the order of 22-23%, and very low with everolimus, as we've previously seen. I think one of the Achilles heels of this regimen is the primary PD rate, which was 34% when used in later line. There are multiple studies that are testing belzutifan in combination across the treatment landscape. So, we have LITESPARK-011, which is looking at the combination of belzutifan plus lenvatinib in the second-line setting. We've got the MK-012 [LITESPARK-012] study, which is looking at belzutifan in various combinations in the frontline setting. So there is a combination with IO plus belzutifan. And so this is also being looked at in that context. And then we also have the LITESPARK-022 study, which is looking at pembrolizumab with belzutifan in the adjuvant setting. So there's a series of studies that will be exploring belzutifan really across the treatment landscape. Many of these studies in combination. Additionally, there are other HIF2α inhibitors that are being developed. We have casdatifan, which is another very potent HIF2α inhibitor. You know, I think pharmacologically, these are different agents. There's a different half-life, different dosing. What is going to be the recommended phase 3 dose for both agents, the EPO suppression levels, the degree of EPO suppression, and sustainability of EPO suppression is very different. So, I think we've seen data from casdatifan from the ARC-20 trial from monotherapy with a respectable response rate, over 30%, primary PD rate hovering just around 10%.  And then we've also seen data of the combination of casdatifan with cabozantinib as well that were recently presented this year. And that agent is also being tested across the spectrum of RCC. It's being looked at in combination with cabozantinib in the PEAK-1 study, and actually just at the KCRS (Kidney Cancer Research Summit), we saw the unveiling of the eVOLVE-RCC trial, which is going to be looking at a volrustomig, which is a PD-1/CTLA-4 inhibitor plus casdatifan compared to nivo-ipi in the frontline setting.  So, we're going to see some competition in this space of the HIF2α inhibitors. I think when we think of mechanism of action in that these are very potent, not a lot of off-target activity, and they target a driver mutation in the disease. And that driver mutation happens very early in the pathogenesis. These are going to be positioned much earlier in the treatment landscape. Dr. Pedro Barata: All these studies, as you're saying, look really promising. And when we talk about them, you mentioned a lot of combinations. And to me, when I think of these agents, it makes a lot of sense to combine because there's not a lot of overlapping toxicities, if you will. But perhaps for some of our listeners, who have not used HIF2α inhibitors in practice yet, and they might be thinking about that, what can you tell us about the safety profile? How do you present it to your patients, and how do you handle things like hypoxia or anemia? How do you walk through the safety profile and tolerability profile of those agents like belzutifan? Dr. Rana McKay: I think these drugs are very different than your traditional TKIs, and they don't cause the classic symptoms that are associated with traditional TKIs that many of us are very familiar with like the rash, hand-foot syndrome, hypertension, diarrhea. And honestly, these are very nuanced symptoms that patients really struggle with the chronicity of being on a chronic daily TKI. The three key side effects that I warn patients about with HIF2α inhibitors are: (1) fatigue; (2) anemia; and (3) hypoxia and dysregulation in the ability to sense oxygen levels. And so, many of these side effects - actually, all of them - are very dose-dependent. They can be very well-managed. So, we can start off with the anemia. I think it's critically important before you even start somebody on belzutifan that you are optimizing their hemoglobin and bone marrow function. Make sure they don't have an underlying iron deficiency anemia. Make sure they don't have B12 or folate deficiency. Check for these parameters. Many patients who have kidney cancer may have some hematuria, other things where there could be some low-level blood loss. So, make sure that those are resolved or you're at least addressing them and supplementing people appropriately. I monitor anemia very closely every 3 to 4 weeks, at least, when people start on these medications. And I do initiate EPO, erythropoietin, should the anemia start to worsen. And I typically use a threshold of around 10g/dL  for implementing utilization of an EPO agent, and that's been done very safely in the context of the early studies and phase 3 studies as well. Now, with regards to the hypoxia, I think it's also important to make sure that you're selecting the appropriate individual for this treatment. People who have underlying COPD, or even those individuals who have just a very high burden of disease in their lung, lymphangitic spread, pleural effusions, maybe they're already on oxygen - that's not an ideal candidate for belzutifan. Something that very easily can be done in the clinic before you think about initiating somebody on this treatment, and has certainly been integrated into some of the trials, is just a 6-minute walk test. You know, have the patient walk around the clinic with one of the MAs, one of the nurses, put the O2 sat on [measuring oxygen saturation], make sure they're doing okay. But these side effects, like I said, are very dose-dependent. Typically, if a patient requires, if the symptoms are severe, the therapy can be discontinued and dose reduced. The standing dose is 120 mg daily, and there's two dose reductions to 80 mg and 40 mg should somebody warrant that dose modification. Dr. Pedro Barata: This is relatively new, right? Like, it was not that we're used to checking oxygen levels, right? In general, we're treating these patients, so I certainly think there's a learning curve there, and some of the points that you highlight are truly critical. And I do share many of those as well in our practice. Since I have you, I want to make sure we touch base on antibody-drug conjugates as well. It's also been a hot area, a lot of developments there. When I think of urothelial carcinoma and renal cell carcinoma, I see it a little bit different. I think perhaps in urothelial carcinoma, antibody-drug conjugates, or ADCs, are somewhat established already. You already mentioned enfortumab vedotin. I might ask you to expand a little bit on that. And then in renal cell carcinoma, we have some ADCs as well that you include in your chapter, and that I would like you to tell us what's coming from that perspective. So, tell us a little bit about how do you see ADCs in general for GU tumors, particularly UC and RCC? Tell us a little bit about the complexity or perhaps the challenges you still see. At the same time, tell us about the successes. Dr. Rana McKay: Stepping back, let's just talk about like the principles and design of ADCs. So, most ADCs have three components. There's a monoclonal antibody that typically targets a cell surface antigen, which is conjugated by a linker, which is the second component, to a payload drug. And typically, that payload drug has been chemotherapy, whether it be topoisomerase or whether it be MMAE or other chemotherapeutic. We can start in the RCC space. There's been multiple antibody-drug conjugates that have been tested. There's antibody-drug conjugates to CD70, which is expressed on clear cell RCC. There's been antibody-drug conjugates to ENPP3, which is also expressed on RCC. There's antibody-drug conjugates to CDH6. And they have different payloads, like I said, whether it be topoisomerase I or other microtubule inhibitors. Now, when we think about kidney cancer, we don't treat this disease with chemotherapy. This disease is treated with immunotherapy. It is treated with treatments that target the VEGF pathway and historically has not been sensitive to chemo. So, I think even though the targets have been very exciting, we've seen very underwhelming data regarding activity, and in some context, seen increased toxicity with the ADCs. So, I think we need to tread lightly in the context of the integration and the testing of ADCs in RCC. We just came back from the KCRS meeting, and there was some very intriguing data about a c-Kit ADC that's being developed for chromophobe RCC, which is, you know, a huge unmet need, these variant tumors that really lack appropriate therapeutics. But I just caution us to tread lightly around how can we optimize the payload to make sure that the tumor that we're treating is actually sensitive to the agent that's targeting the cell kill. So, that's a little bit on the ADCs in RCC. I still think we have a long way to go and still in early testing. Now, ADCs for UC are now the standard of care. I think the prototypical agent, enfortumab vedotin, is a nectin-4-directed ADC that's conjugated to an MMAE payload and was the first ADC approved for advanced urothelial, received accelerated approval following the EV-201 trial, which was basically a multicenter, single-arm study that was investigating EV in cisplatin-ineligible patients with advanced urothelial carcinoma, and then ultimately confirmed in the EV-301 study as well. And so, that study ended up demonstrating the support superiority of EV from an overall survival standpoint, even PFS standpoint. Building on that backbone is the EV-302 study, which tested EV in combination with pembrolizumab versus platinum-based chemotherapy in the frontline setting. And that was a pivotal, landmark study that, like I said, has displaced platinum therapy as a frontline treatment for people with advanced urothelial carcinoma. And when we think about that study and the median overall survival and just how far we've come in urothelial cancer, the median OS with EV-pembro from that trial was 31 and a half months. I mean, that's just incredible. The control arm survival was 16 and a half months. The hazard ratio for OS, 0.47. I mean this is why when this data was presented, it was literally a standing ovation that lasted for several minutes because we just haven't seen data that have looked that good. And there are other antibody-drug conjugates that are being tested. We've all been involved in the saga with sacituzumab govitecan, which is a trophoblast cell surface antigen 2 (Trop-2) targeted ADC with a topoisomerase I payload. It was the second ADC to receive approval, but then that approval was subsequently withdrawn when the confirmatory phase 3 was negative, the TROPiCS-04 trial. So, approval was granted based off of the TROPHY-U-01, single-arm, phase 2 study, demonstrating a response rate of around 28% and a PFS of, you know, about 5 and a half months. But then failure to show any benefit from an OS standpoint. And I think there's a lot of controversy in the field around whether this agent still has a role in advanced urothelial carcinoma. And I think particularly for individuals who do not have molecular targets, like they're not HER2-amplified or have HER2-positivity or FGFR or other things like that. Dr. Pedro Barata: Fantastic summary, Rana. You were talking about the EV, and it came to mind that it might not be over, right, for the number of ADCs we use in clinical practice in the near future. I mean, we've seen very promising data for ADC against the HER2, right, and over-expression. It also can create some challenges, right, in the clinics because we're asking to test for HER2 expression. It's almost like, it's not exactly the same to do it in breast cancer, but it looks one more time that we're a little bit behind the breast cancer field in a lot of angles. And also has vedotin as a payload. Of course, I'm referring to disitamab vedotin, and there's very elegant data described by you in your review chapter as well. And it's going to be very interesting to see how we sequence the different ADCs, to your point as well. So, before we wrap it up, I just want to give you the opportunity to tell us if there's any area that we have not touched, any take-home points you'd like to bring up for our listeners before we call it a day. Dr. Rana McKay: Thank you so much. I have to say, you know, I was so excited at ASCO this year looking at the GU program. It was fantastic to see the progress being made, novel therapeutics that really there's a tremendous excitement about, not just in RCC and in UC, but also in prostate cancer, thinking about the integration of therapies, not just for people with refractory disease that, even though our goal is to improve survival, our likelihood of cure is low, but also thinking about how do we integrate these therapies early in the treatment landscape to enhance cure rates for patients, which is just really spectacular. We're seeing many of these agents move into the perioperative setting or in combination with radiation for localized disease. And then the special symposium on biomarkers, I mean, we've really come a long, long way. And I think that we're going to continue to evolve over the next several years. I'm super excited about where the field is going in the treatment of genitourinary malignancies. Dr. Pedro Barata: Oh, absolutely true. And I would say within the Annual Meeting, we have outstanding Educational Sessions. And just a reminder to the listeners that actually that's where the different teams or topics for the Educational Book chapters come from, from actually the educational sessions from ASCO. And your fantastic chapter is an example of that, right, focusing on advanced GU tumors. So, thank you so much, Rana, for taking the time, sharing your insights with us today on the podcast. It was a fantastic conversation as always. Dr. Rana McKay: My pleasure. Thanks so much for having me, Dr. Barata. Dr. Pedro Barata: Of course.  And thank you to our listeners for your time today. You will find the link to the article discussed today in the transcript of this episode. I also encourage you to check out the 2025 ASCO Educational Book. You'll find an incredible wealth of information there. It's free, available online, and you'll find, hopefully, super, super important information on the key science and issues that are shaping modern oncology, as we've heard from Dr. McKay and many other outstanding authors. So, thank you, everyone, and I hope to see you soon. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:        Dr. Pedro Barata @PBarataMD Dr. Rana McKay @DrRanaMcKay Follow ASCO on social media:        @ASCO on X (formerly Twitter)        ASCO on Bluesky       ASCO on Facebook        ASCO on LinkedIn        Disclosures:     Dr. Pedro Barata: Stock and Other Ownership Interests: Luminate Medical Honoraria: UroToday Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck  Dr. Rana McKay: Consulting or Advisory Role: Janssen, Novartis, Tempus, Pfizer, Astellas Medivation, Dendreon, Bayer, Sanofi, Vividion, Calithera, Caris Life Sciences, Sorrento Therapeutics, AVEO, Seattle Genetics, Telix, Eli Lilly, Blue Earth Diagnostics, Ambrx, Sumitomo Pharma Oncology, Esiai, NeoMorph, Arcus Biosciences, Daiichi Sankyo, Exelixis, Bristol Myers Squibb, Merck, Astrazeneca, Myovant Research Funding (Inst.): Bayer, Tempus, AstraZeneca, Exelixis, Bristol Myers Squibb, Oncternal Therapeutics, Artera    

Devotion IX - Choices - Josh. 24:15

Our hosts have plenty of energy and stuff to talk about following Benjamin's road-trip vacation. After Benjamin's discussion of hot dog prices and charitable clowns, this weeks show starts off with a review of the 2026 BMW iX xDrive60. With over 350 miles of range on tap, this EV should have been the perfect chariot for a road trip, but Benjamin did have a few issues along his trip. Additionally, the guys go into a deep discussion about carbon fiber, clamshell hoods, and other premium EVs. Then Sami goes nuts over news following this year's Monterey Car Week and Pebble Beach Concours. From Lexus to Infiniti to Nissan and BMW, there's all kinds of fun news to pour over, and laugh about. Thanks for listening!

La pimienta es hoy un condimento muy común y de precio asequible, esencial en cocinas de todo el mundo, pero no siempre fue así. Proviene de la región de Malabar, en el sur de la India y se convirtió en un importante motor de la economía y el comercio durante miles de años. Desde la antigüedad, la pimienta fue un producto valioso y muy demandado. En el Egipto de los faraones se usaba en la cocina, pero también en ritos de momificación tal y como los arqueólogos pudieron comprobar cuando encontraron dos granos de pimienta en las fosas nasales de la momia de Ramsés II. De Egipto pasó a otras zonas del Mediterráneo. En Grecia era bien conocida, pero su alto coste limitaba su consumo a los que eran muy ricos. Debía ser tan cara que no aparece ni siquiera mencionada en el antiguo testamento Su escasez se debía a que había que traerla desde la India mediante una ruta muy larga que iba por el mar Rojo y el mar Arábigo. Se desconocía, además, de que planta en concreto provenía. En tiempos del Imperio Romano ese comercio se expandió como nunca antes. Los romanos, que habían creado una gran zona comercial en el Mediterráneo, importaron durante siglos grandes cantidades de pimienta que transformó su gastronomía y la economía del imperio. La conquista romana de Egipto en el 30 a.C. les abrió el mar Rojo de par en par. Eso les facilitaba el acceso directo a la India. De como las flotas romanas llegaban hasta la India da fe un diario de viaje del siglo I, el "Periplo del mar eritreo", en el que el autor detalla las rutas comerciales, los puertos de recalada y los productos con los que había que comerciar. La pimienta siguió siendo costosa, pero su preció descendió, lo que hizo de esta especia un condimento muy popular en la Roma imperial. Tras la caída del imperio romano, bizantinos, persas y árabes se fueron sucediendo en el control del comercio con la India. En el siglo IX, los árabes ya eran los dueños de la ruta entre los puertos indios de Malabar y los del golfo Pérsico y el mar Rojo. La pimienta se integró en la cocina islámica y fue incluso elogiada por eruditos como Avicena. Una vez en las costas del Mediterráneo, venecianos y genoveses monopolizaban su distribución. Su escasez la convirtió en uno de los símbolos de riqueza más visibles de la Europa medieval. Los reyes y aristócratas la empleaban en la cocina y trataban de que sus existencias de pimienta fuesen muy visibles en los banquetes. Cualquiera con dinero estaba dispuesto a pagar por ella, algo que hizo prosperar a las repúblicas marítimas italianas que se encargaban de traerla desde los puertos del Levante. La caída de Constantinopla en 1453 encareció aún más el producto porque los otomanos elevaron los peajes. Eso empujó a los portugueses, que ya estaban explorando la costa africana, a buscar rutas alternativas. En 1498 Vasco da Gama llegó a Calicut acabando así con el monopolio que durante siglos habían tenido árabes y venecianos. Durante más de un siglo los portugueses establecieron en la India factorías fortificadas como la de Goa, desde donde controlaban el comercio de pimienta ahuyentado a los competidores. Eso redujo sustancialmente los precios en Europa ya que se eliminaban los intermediarios. Se llevaron también su cultivo a Brasil, lo que redundó en un incremento de la oferta. Pero seguía siendo interesante desde el punto de vista comercial, por lo que otras potencias como los Países Bajos, Inglaterra y Francia entraron en el mercado con sus compañías de las Indias Orientales. En sólo unas décadas consiguieron que llegase tanta pimienta a los mercados europeos que su precio descendió hasta convertir la otrora deseada especia en una commodity más. En el siglo XVIII la pimienta ya era algo cotidiano, pero había conseguido cambiar el mundo. Gracias a ella prosperaron ciudades como Lisboa y Ámsterdam, los beneficios obtenidos por su venta financiaron todo tipo de innovaciones y fue la palanca que los europeos utilizaron para establecerse en Asia hasta bien entrado el siglo XX. En El ContraSello: 0:00 Introducción 4:21 El imperio de la pimienta 1:08:49 Vlad Tepes "el empalador" 1:17:51 ¿Qué sabían los alemanes del Holocausto?" Bibliografía: “Las especias: Historia de una tentación” de Jack Turner - https://amzn.to/3HWOGng “Especias” de Roger Crowley - https://amzn.to/4n2GqB5 “Historia de las especias” de Román Hereter - https://amzn.to/3JFekxk “El origen de las especias” de Thomas Reinerstensen - https://amzn.to/4209GQR #FernandoDiazVillanueva #pimienta #especias Escucha el episodio completo en la app de iVoox, o descubre todo el catálogo de iVoox Originals

La pimienta es hoy un condimento muy común y de precio asequible, esencial en cocinas de todo el mundo, pero no siempre fue así. Proviene de la región de Malabar, en el sur de la India y se convirtió en un importante motor de la economía y el comercio durante miles de años. Desde la antigüedad, la pimienta fue un producto valioso y muy demandado. En el Egipto de los faraones se usaba en la cocina, pero también en ritos de momificación tal y como los arqueólogos pudieron comprobar cuando encontraron dos granos de pimienta en las fosas nasales de la momia de Ramsés II. De Egipto pasó a otras zonas del Mediterráneo. En Grecia era bien conocida, pero su alto coste limitaba su consumo a los que eran muy ricos. Debía ser tan cara que no aparece ni siquiera mencionada en el antiguo testamento Su escasez se debía a que había que traerla desde la India mediante una ruta muy larga que iba por el mar Rojo y el mar Arábigo. Se desconocía, además, de que planta en concreto provenía. En tiempos del Imperio Romano ese comercio se expandió como nunca antes. Los romanos, que habían creado una gran zona comercial en el Mediterráneo, importaron durante siglos grandes cantidades de pimienta que transformó su gastronomía y la economía del imperio. La conquista romana de Egipto en el 30 a.C. les abrió el mar Rojo de par en par. Eso les facilitaba el acceso directo a la India. De como las flotas romanas llegaban hasta la India da fe un diario de viaje del siglo I, el "Periplo del mar eritreo", en el que el autor detalla las rutas comerciales, los puertos de recalada y los productos con los que había que comerciar. La pimienta siguió siendo costosa, pero su preció descendió, lo que hizo de esta especia un condimento muy popular en la Roma imperial. Tras la caída del imperio romano, bizantinos, persas y árabes se fueron sucediendo en el control del comercio con la India. En el siglo IX, los árabes ya eran los dueños de la ruta entre los puertos indios de Malabar y los del golfo Pérsico y el mar Rojo. La pimienta se integró en la cocina islámica y fue incluso elogiada por eruditos como Avicena. Una vez en las costas del Mediterráneo, venecianos y genoveses monopolizaban su distribución. Su escasez la convirtió en uno de los símbolos de riqueza más visibles de la Europa medieval. Los reyes y aristócratas la empleaban en la cocina y trataban de que sus existencias de pimienta fuesen muy visibles en los banquetes. Cualquiera con dinero estaba dispuesto a pagar por ella, algo que hizo prosperar a las repúblicas marítimas italianas que se encargaban de traerla desde los puertos del Levante. La caída de Constantinopla en 1453 encareció aún más el producto porque los otomanos elevaron los peajes. Eso empujó a los portugueses, que ya estaban explorando la costa africana, a buscar rutas alternativas. En 1498 Vasco da Gama llegó a Calicut acabando así con el monopolio que durante siglos habían tenido árabes y venecianos. Durante más de un siglo los portugueses establecieron en la India factorías fortificadas como la de Goa, desde donde controlaban el comercio de pimienta ahuyentado a los competidores. Eso redujo sustancialmente los precios en Europa ya que se eliminaban los intermediarios. Se llevaron también su cultivo a Brasil, lo que redundó en un incremento de la oferta. Pero seguía siendo interesante desde el punto de vista comercial, por lo que otras potencias como los Países Bajos, Inglaterra y Francia entraron en el mercado con sus compañías de las Indias Orientales. En sólo unas décadas consiguieron que llegase tanta pimienta a los mercados europeos que su precio descendió hasta convertir la otrora deseada especia en una commodity más. En el siglo XVIII la pimienta ya era algo cotidiano, pero había conseguido cambiar el mundo. Gracias a ella prosperaron ciudades como Lisboa y Ámsterdam, los beneficios obtenidos por su venta financiaron todo tipo de innovaciones y fue la palanca que los europeos utilizaron para establecerse en Asia hasta bien entrado el siglo XX. En El ContraSello: 0:00 Introducción 4:21 El imperio de la pimienta 1:08:49 Vlad Tepes "el empalador" 1:17:51 ¿Qué sabían los alemanes del Holocausto?" Bibliografía: “Las especias: Historia de una tentación” de Jack Turner - https://amzn.to/3HWOGng “Especias” de Roger Crowley - https://amzn.to/4n2GqB5 “Historia de las especias” de Román Hereter - https://amzn.to/3JFekxk “El origen de las especias” de Thomas Reinerstensen - https://amzn.to/4209GQR #FernandoDiazVillanueva #pimienta #especias

"Hommikumaa vägevate" IX hooaja keskmes on saladused; salaseltsid, salamõrvarid ja salaagendid. Üheksanda saate teema on Palestiina äärmusrühmitus Hamās.

"Hommikumaa vägevate" IX hooaja keskmes on saladused; salaseltsid, salamõrvarid ja salaagendid. Kaheksas saade kõneleb Jaapani kurikuulsast viimsepäevasektist Aum Shinrikyō'st ja selle juhist Shōkō Asaharast (1955-2018).

Mark and Alex discuss with the last remaining Dark Aeons, and introduce the "ultimate" boss Penance. The boys also go into detail on how to boost character stats to even be able to on these very powerful foes and stand a chance at victory. This episode finishes off the last remaining side content the boys want to go over, so the only thing left to do is to finish the story!If you're searching for the beginning of the Final Fantasy X or IX series, check the quick info below!Start of the Final Fantasy X series is ⁠⁠⁠⁠⁠⁠⁠⁠episode 43⁠⁠⁠⁠⁠⁠⁠⁠Start of the Final Fantasy IX series is ⁠⁠⁠⁠⁠⁠⁠⁠episodes 6

"Hommikumaa vägevate" IX hooaja keskmes on saladused; salaseltsid, salamõrvarid ja salaagendid. Seitsmes saade toob meie ette Tamili Tiigrite terroriorganisatsiooni ajaloo ning pika võitlustee (1976-2009) singlite natsionalismi ja Sri Lanka riigi vastu.

Episode Summary:In the third and final chapter of our Star Wars original trilogy series, Scott, Candice, and guests take the mic with a few extra drinks and zero fear of ruffling fanboy feathers. This episode is all about changing canon, fixing missed opportunities, and imagining what could have been in the galaxy far, far away.From rapid-fire “Jedi or Sith” questions to deep dives on Ewok backstories, Captain Phasma fan theories, and why Boba Fett might be overrated, no character is safe. We pitch spin-offs for the underappreciated, debate which moments in The Rise of Skywalker should be rewritten, and even ask the ultimate question—should Episodes VII, VIII, and IX have been made at all?Plus, you'll hear:Which character one host would happily launch out of a cannon.Why the Luke and Leia kiss still gives everyone the ick.A theory that turns Jar Jar Binks into a secret Sith Lord.A surprisingly dark fan theory about Obi-Wan and the fate of Owen and Beru.Our most unpopular Star Wars opinions (brace yourself, purists).It's chaotic, it's passionate, and it's exactly the kind of spirited debate you'd expect from Disney adults who have been drinking since morning. Grab a drink, open your mind, and prepare for some serious Star Wars heresy.Listen now for laughs, hot takes, and maybe a new perspective on your favorite (or least favorite) parts of the saga.

Customer service used to be seen as a cost center. Something to manage, streamline, and, if possible, outsource or automate. But what happens when AI shifts that narrative entirely? In this episode of Tech Talks Daily, I sat down with Ryan Peterson, Chief Product Officer at Concentrix, to unpack how customer service is being reimagined as a revenue-driving engine. With 430,000 advisors handling millions of calls for brands across every major industry, Concentrix isn't theorizing about the future. They're building it. Ryan shares how blending human empathy with AI efficiency is creating faster resolutions, stronger loyalty, and in some cases, serious bottom-line results. One example saw upsell revenue rise from $500,000 to $1.6 million per month simply by supporting human agents with smart, context-aware AI assistants. We also talk about the evolution of the agent's role. Far from replacing jobs, AI is creating a new class of specialists called agent engineers. These are people responsible for maintaining, optimizing, and guiding AI systems that now work alongside human teams. This shift is opening doors for deeper personalization, real-time translation, and richer customer engagement across channels and geographies. Ryan also gives us a behind-the-scenes look at Concentrix's award-winning IX...Low Platform, which was recently named Intelligent Personal Assistant of the Year. Supporting over 7,000 AI agents and offering robust security and integration capabilities, the platform is designed for scale and resilience. It's not just handling simple FAQs. From legal contract analysis to proactive service interventions, these AI agents are transforming how enterprise support works. We close with a forward-looking conversation about hyper-personalization, ethical AI integration, and the long-term role of trust in CX strategy. Ryan's optimism is clear, but it's grounded in metrics, use cases, and a deep understanding of what businesses actually need to deliver meaningful customer experiences. If you're curious about what customer service looks like when AI and humans collaborate effectively, or what it takes to move from handling complaints to driving conversion, this is the conversation you'll want to hear.

Desde Montserrat, el macizo montañoso que fascina y embruja, la montaña mágico sagrada de Cataluña, marcada por la leyenda, el hallazgo de una Virgen Negra tras la aparición de unas extrañas luces en los cielos en el siglo IX, la Virgen de Montserrat, La Moreneta, hoy en La España Mágica de Más de Uno nuestro compañero Fran Contreras nos desvela, junto al escritor y periodista Javier Sierra, las claves y secretos de su nueva novela: El Plan Maestro, publicado por la Editorial Planeta, cuatrocientas ochenta y cinco páginas, que nos invita a descubrir los secretos del arte. 

"Hommikumaa vägevate" IX hooaja keskmes on saladused; salaseltsid, salamõrvarid ja salaagendid. Kuues saade jutustab Iisraeli kõikvõimsa salateenistuse Mossadi loo.

Don't Stop Believing, Part 3 A sermon by Pastor Richard Sfameni, Lead Pastor at Victory Church in Providence, RI I. Introduction Welcome and purpose of the podcast: sharing powerful messages from services. Victory Church's mission: reaching the lost, restoring the broken, reviving believers. Call to engagement: readiness to receive the Word of God. Message title: "Don't Stop Believing" (better phrased as "Keep Believing"). Central theme: The necessity and critical importance of living by faith. II. The Nature and Gift of Faith Biblical definition: Faith as the “substance of things hoped for, the evidence of things not seen” (Hebrews 11:1). Faith is confidence in God's promises and His character. Every believer has a “seed/measure” of faith—faith given by God (Romans 12). Faith as a muscle: grows stronger through use, challenges, and spiritual exercise. Warning against comparing levels of faith among believers. Personal testimony: growth through spiritual trials and resistance, analogy to physical training. III. The Importance of Faith (Scriptural Emphasis) Essential for pleasing God: “Without faith it is impossible to please God” (Hebrews 11:6). Two elements: belief that God exists and that He rewards those who seek Him. Faith is required in every circumstance; God knows individual limits and provides grace for endurance. IV. Faith as the Primary Metric in the Church Examination of Paul's concern for faith in the church (1 Thessalonians 3). Paul's repeated focus on the faith of the congregation rather than external measures. What Paul didn't emphasize: not the size, budget, or facilities of the church. Critique of cultural (non-biblical) values in assessing church success. Dangers of equating “bigness” or material signs with spiritual greatness. Examples: 85% of American churches have fewer than 200 people, illustrating that size is not the key measure. Example from church history: Charles Spurgeon's conversion in a small chapel, demonstrating greatness is about spiritual impact, not size. V. Keeping Faith Central The importance of keeping “the main thing the main thing”—focus on the growth and exercise of faith. Individuals and churches must prioritize spiritual metrics over worldly metrics. VI. Lessons from the Heroes of Faith Review of “the cloud of witnesses” in Hebrews 11-12. Faith exemplars: those who faced challenges and saw God's faithfulness. The value of biographies/autobiographies of Christians for practical insights into a life of faith. Example: George Mueller's dependence on faith for provision. Recognition of current church members as examples of faith and faithfulness. VII. Hindrances to Faith Identifying and “laying aside every weight”: Bitterness, unforgiveness, distractions, and past failures. Analogy of running a race: shed anything that slows spiritual progress. Biblical example: Paul “forgets what is behind and presses on.” The need for “divine forgetfulness” and remembrance of what matters (the cross, God's promises). VIII. Perseverance of Faith Faith requires perseverance, endurance—keep moving forward despite obstacles and struggles. Examples of perseverance from secular figures (Walt Disney, Einstein, Churchill, Lincoln) to illustrate endurance. Claim: with the Spirit of God, believers have even greater potential for perseverance. Encouragement for listeners to resolve to succeed and trust in God's enabling power. IX. The Focus of Faith: Fixing Eyes on Jesus The source and goal (“author and finisher”) of faith is Jesus. Spiritual direction comes from focusing on Christ—not on people or circumstances. Analogy: Just as a runner focuses on the finish line, Christians must fix their gaze on Jesus. Biblical example: Peter walking on water by looking at Jesus, sinking when distracted by the storm (Matthew 14). Isaiah 26:3—Perfect peace comes from “mind stayed on Thee.” Hymn: “Turn Your Eyes Upon Jesus” used to reinforce the point. The danger of spiritual distraction; importance of continual refocusing on Christ. X. The Cross as Spiritual North Point Story: Beach analogy—currents can pull us off course unnoticed, requiring realignment. The cross of Christ as a central, guiding reference for believers. Regular course corrections are necessary due to “the currents” of worldly distractions and sin. Importance of always coming back to Christ and the cross. XI. Application and Call to Action Self-examination: Is your faith growing? Are you focused on Jesus? Urge to lay aside distractions/weights and make the necessary spiritual adjustments. Invitaton for reflection, response, prayer, and renewed commitment as the service closes.

La leyenda de la papisa Juana cuenta la historia de una mujer que, en el siglo IX, habría ascendido al papado bajo el nombre de Juan VIII, disfrazada de hombre. Según el relato, Juana, nacida en Maguncia, destacó desde joven por su inteligencia y ansias de conocimiento. En una época donde la educación estaba reservada a los hombres, se dice que se disfrazó para ingresar a un monasterio y luego estudiar en Atenas. Su erudición la llevó a Roma, donde, bajo apariencia masculina, escaló en la jerarquía eclesiástica hasta ser elegida papa. La historia culmina con un desenlace trágico: durante una procesión, Juana dio a luz, revelando su verdadera identidad. Indignada, la multitud la habría ejecutado. Aunque fascinante, esta historia carece de sustento histórica. Los primeros registros aparecen en crónicas del siglo XIII, como la de Martín de Opava, y muchos historiadores consideran que es un mito creado para satirizar a la Iglesia o reflejar tensiones políticas de la época. · Canal de Telegram: https://t.me/lacontracronica · “Contra la Revolución Francesa”… https://amzn.to/4aF0LpZ · “Hispanos. Breve historia de los pueblos de habla hispana”… https://amzn.to/428js1G · “La ContraHistoria de España. Auge, caída y vuelta a empezar de un país en 28 episodios”… https://amzn.to/3kXcZ6i · “Lutero, Calvino y Trento, la Reforma que no fue”… https://amzn.to/3shKOlK · “La ContraHistoria del comunismo”… https://amzn.to/39QP2KE Apoya La Contra en: · Patreon... https://www.patreon.com/diazvillanueva · iVoox... https://www.ivoox.com/podcast-contracronica_sq_f1267769_1.html · Paypal... https://www.paypal.me/diazvillanueva Sígueme en: · Web... https://diazvillanueva.com · Twitter... https://twitter.com/diazvillanueva · Facebook... https://www.facebook.com/fernandodiazvillanueva1/ · Instagram... https://www.instagram.com/diazvillanueva · Linkedin… https://www.linkedin.com/in/fernando-d%C3%ADaz-villanueva-7303865/ · Flickr... https://www.flickr.com/photos/147276463@N05/?/ · Pinterest... https://www.pinterest.com/fernandodiazvillanueva Encuentra mis libros en: · Amazon... https://www.amazon.es/Fernando-Diaz-Villanueva/e/B00J2ASBXM Escucha el episodio completo en la app de iVoox, o descubre todo el catálogo de iVoox Originals

Host Brandon Contes interviews founder of The IX newsletter, The Next, and author of "Becoming Caitlin Clark," Howard Megdal. With the WNBA All-Star Game coming up, Brandon and Howard discuss his new book along with a wide range of topics including Caitlin Clark's talent and her rise in popularity, how the media covers Clark, the WNBA's role and its responsibility in Clark's popularity with the rise of women's basketball, and more.NOTE: We recorded before Clark re-aggravated her groin injury on July 15.-1:51: Focusing on women's sports coverage-6:10: “Becoming Caitlin Clark” book-12:44: Caitlin Clark talk-26:01: WNBA talk, league growth, and their preparation for Caitlin Clark's fame-42:35: Christine Brennan's Caitlin Clark book-45:12: New York Mets seasonDownload the Awful Announcing Podcast:Listen on AppleListen on SpotifyAwful Announcing on XAwful Announcing on FacebookAwful Announcing on InstagramAwful Announcing on ThreadsAwful Announcing on BlueSkyAwful Announcing on LinkedInAwful Announcing on YouTube Hosted on Acast. See acast.com/privacy for more information.

Ben and Adam accidentally told Grant to meet at the wrong bar, so it's just the two of them this week. After discussing the weekly news, the co-hosts jump into the first five issues of the Kylo Ren: Legacy of Vader comic. The amount of connection and backfilling that Charles Soule is able to do between Episodes VIII and IX is astonishing. 

Scripture: Matthew 13:44-46 Key Takeaways:  — Finding — Assessing — Selling — Rejoicing — Buying + Jesus is the one thing worth losing all things just to have + This is how we become a Christian — Jesus is not your Savior unless He is your Treasure “How sweet all at once it was for me to be rid of those fruitless joys which I had once feared to lose… You drove them from me, you who are the true, the sovereign joy. You drove them from me and took their place, you who are sweeter than all pleasure… you who outshine all light… you who surpass all honor…O Lord my God, my Light, my Wealth, and my Salvation.” – Confessions, IX, 1. — Philippians 3:4-11 + This is how we live as a Christian — Philippians 3:7-8 + This is how we overcome temptation — Hebrews 11:24-26